The country is holding talks with the pharmaceutical company and the Pan American Health Organization (PAHO) regarding the quadrivalent vaccine TAK-003, the first recommended by the World Health Organization (WHO) against dengue developed by the Japanese pharmaceutical company Takeda.
This was stated by Eladio Pérez, Vice Minister of Collective Health of the Ministry of Public Health, who said that as soon as this vaccine is available, the country will do everything possible to acquire it.
“We understand that it is effective and safe, in addition to reducing mortality, it significantly reduces the incidence of serious cases and hospitalizations,” said the official, when answering questions from Listín Diario on the subject, at a time when the Dominican Republic is going through an epidemic. of dengue that has left nine confirmed deaths and more than 10,500 suspected cases of the disease.
overdemand
Meanwhile, the excess demand for care continues in the areas of consultations, emergencies and hospitalizations in public and private health centers, especially those aimed at pediatric care, since those most impacted currently are those under 19 years of age, with highest incidence among those between five and 16 years old.
The greatest pressure is registered in clinics and hospitals in Greater Santo Domingo, where relatives frequently complain that they have to visit various health establishments to obtain an inpatient bed.
Yesterday, the Hugo Mendoza Pediatric Hospital reported 82 suspected dengue patients admitted, the Robert Reid Cabral had 58 hospitalized in its wards; Marcelino Vélez Santana, 20 patients; Arturo Grullón and Jaime Mota, from Santiago and Barahona, and Félix María Goico, four patients, had the same number of 20 patients. Yesterday, the Plaza de la Salud General Hospital had 29 dengue patients hospitalized. and six in the emergency area.
2023-10-07 04:00:00
#Country #interested #dengue #vaccine
